**About the Editors**

**Paolo Mulatero** serves as a full professor of Internal Medicine at the University of Torino, Italy, where he is responsible for the Laboratory of Genetics and Molecular Biology of Arterial Hypertension and he is also head of the Hypertension Unit. After he completed his medical degree in 1991 at the University of Torino, he completed his residency in Internal Medicine at the same university in 1997. Between 1992 and 1993, he worked as a research fellow at the Blood Pressure Unit in Glasgow for studies on glucocorticoid receptors. Between 1995 and 1997, he worked as a research fellow at the Department of Pathologie Vasculaire et Endocrinologie R´enale of the Coll`ege de France INSERM U36, Paris, France (Directed by Prof. P. Corvol), where he studied the 11βhydroxylase and aldosterone synthase genes and their roles in essential and secondary hypertension. Prof Mulatero has over 25 years of clinical and basic research experience in the field of arterial hypertension, particularly primary aldosteronism. In that regard, his research significantly contributed to demonstrating that primary aldosteronism is the most frequent form of secondary hypertension and to our understanding of the genetic determinants of both sporadic and familial forms. Paolo Mulatero is currently a member of the Endocrine Society, European Society of Hypertension, Italian Society of Hypertension, chairman of the ESH Endocrine Hypertension Working Group, and member of the Executive Committee of the Italian Society of Hypertension. He has delivered over 40 invited lectures worldwide and authored 190 scientific publications with an IF > 1000 and over 10.000 citations.

**Silvia Monticone** earned her Medical Doctor Degree in 2007 from the University of Torino. In 2013, she completed a residency in Internal Medicine and, in 2016, she earned a Ph.D. at the same university. Dr. Monticone has a strong interdisciplinary skillset with research interests spanning both basic science and clinical research topics in the field of arterial hypertension and, in particular, primary aldosteronism. In 2011, she spent one year as a research fellow at Georgia Health Sciences University in the Department of Physiology, where she studied, in the laboratory directed by Prof. W.E. Rainey), the molecular mechanisms responsible for hyperaldosteronism in carriers of KCNJ5 mutations. She has authored over 70 scientific publications and she actively participates in national and international conferences. Dr. Monticone is a member of the Italian Hypertension Society since 2008 and, in 2012, she won the Italian Hypertension Society grant. She currently works as a research scientist at the University of Torino, Italy.
